Skip to search formSkip to main contentSkip to account menu

CS 905

Known as: CS-905 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

azelnidipine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Biliary excretion of azelnidipine, a calcium antagonist, in rats
Background and Aims:  Azelnidipine (CS‐905) is a novel dihydropyridine calcium antagonist that is known to be excreted in feces… 
2000
2000
Phase I study of CS-905, a new calcium antagonist-III : a multiple dose study on healthy volunteers
2000
2000
Phase I study of CS-905, a new calcium antagonist-III : a multiple dose study on healthy volunteers
1995
1995
[Studies of novel 1,4-dihydropyridine Ca antagonist CS-905. I. Measurement of partition coefficient (log P) by high performance liquid chromatography (HPLC)].
A new 1,4-dihydropyridine derivative, CS-905, currently under development as a Ca antagonist, showed a gradual onset and long… 
1995
1995
Azelnidipine (CS‐905), A Novel Dihydropyridine Calcium Channel Blocker with Gradual Onset and Prolonged Duration of Action
1994
1994
Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
CS-905 is a dihydropyridine calcium channel antagonist which stands out for its prolonged hypotensive effect, and which is… 
1994
1994
Effects of dihydropyridine Ca blockers on the renal function in nephrotic spontaneously hypertensive rat (SHR).
An animal model having both hypertension and reduced renal function was produced by intraperitoneal injection of puromycin… 
1990
1990
Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR.
To investigate the central and regional hemodynamics after long-term administration of CS-905, a novel calcium blocker, we… 
1990
1990
Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs.
CS-905, (+-)-3-(1-diphenylmethylazetidin-3-yl)5-isopropyl 2-amino-1,4-dihydro-6-methyl-4-(m-nitrophenyl)-3,5-pyridine-dicarboxy… 
1989
1989
Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR.
CS-905 is a potent dihydropyridine calcium blocker that has a gradual and long-lasting antihypertensive action with little… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)